Matches in Wikidata for { <http://www.wikidata.org/entity/Q70558147> ?p ?o ?g. }
- Q70558147 description "article scientifique publié en 1993" @default.
- Q70558147 description "artikull shkencor i botuar më 01 janar 1993" @default.
- Q70558147 description "artículu científicu espublizáu en xineru de 1993" @default.
- Q70558147 description "im Januar 1993 veröffentlichter wissenschaftlicher Artikel" @default.
- Q70558147 description "scientific article published on 01 January 1993" @default.
- Q70558147 description "wetenschappelijk artikel" @default.
- Q70558147 description "наукова стаття, опублікована в січні 1993" @default.
- Q70558147 name "Phase I study using desferrioxamine and iron sorbitol citrate in an attempt to modulate the iron status of tumor cells to enhance doxorubicin activity" @default.
- Q70558147 name "Phase I study using desferrioxamine and iron sorbitol citrate in an attempt to modulate the iron status of tumor cells to enhance doxorubicin activity" @default.
- Q70558147 name "Phase I study using desferrioxamine and iron sorbitol citrate in an attempt to modulate the iron status of tumor cells to enhance doxorubicin activity" @default.
- Q70558147 type Item @default.
- Q70558147 label "Phase I study using desferrioxamine and iron sorbitol citrate in an attempt to modulate the iron status of tumor cells to enhance doxorubicin activity" @default.
- Q70558147 label "Phase I study using desferrioxamine and iron sorbitol citrate in an attempt to modulate the iron status of tumor cells to enhance doxorubicin activity" @default.
- Q70558147 label "Phase I study using desferrioxamine and iron sorbitol citrate in an attempt to modulate the iron status of tumor cells to enhance doxorubicin activity" @default.
- Q70558147 prefLabel "Phase I study using desferrioxamine and iron sorbitol citrate in an attempt to modulate the iron status of tumor cells to enhance doxorubicin activity" @default.
- Q70558147 prefLabel "Phase I study using desferrioxamine and iron sorbitol citrate in an attempt to modulate the iron status of tumor cells to enhance doxorubicin activity" @default.
- Q70558147 prefLabel "Phase I study using desferrioxamine and iron sorbitol citrate in an attempt to modulate the iron status of tumor cells to enhance doxorubicin activity" @default.
- Q70558147 P1433 Q70558147-CF78B8F5-8144-43F7-818A-ED60F370119C @default.
- Q70558147 P1476 Q70558147-7B2FA691-24D9-4B87-88F3-9D7F7B41410F @default.
- Q70558147 P2093 Q70558147-0D68243B-262A-4191-A408-69E15D80C71D @default.
- Q70558147 P2093 Q70558147-1C205DDF-0314-4C39-8BFF-39D3EAD5CF48 @default.
- Q70558147 P2093 Q70558147-398DC2D0-5A80-4846-9505-0D038E8A1E83 @default.
- Q70558147 P2093 Q70558147-42E5636F-DD18-470A-A3B1-52E04FD63410 @default.
- Q70558147 P2093 Q70558147-8272C43B-6D2C-4B30-A54C-AF7EE7E96783 @default.
- Q70558147 P2093 Q70558147-A8DBD6C5-BBA3-4D7E-BDD5-29059DEF8134 @default.
- Q70558147 P2093 Q70558147-F24751E9-3DCD-4A6D-9BBC-2C85FDBCD049 @default.
- Q70558147 P2093 Q70558147-F8B15818-EAC0-4222-8EF2-0091B56DEFED @default.
- Q70558147 P2860 Q70558147-0487F4F9-4D12-4972-B364-C535B169A78F @default.
- Q70558147 P2860 Q70558147-055BFA51-A85F-471F-9013-A51D6C2CA059 @default.
- Q70558147 P2860 Q70558147-0BAD1041-B951-40F4-8C8F-6D5478089CF5 @default.
- Q70558147 P2860 Q70558147-0BD41364-11D8-4F6A-990E-ECAA63D10E08 @default.
- Q70558147 P2860 Q70558147-12F0D28F-D1C5-4B73-B0F5-0FEB85547571 @default.
- Q70558147 P2860 Q70558147-17196F07-02E8-41F6-A3D9-26FBDAEBB951 @default.
- Q70558147 P2860 Q70558147-1FD9F2F8-A6A5-4C97-8D80-908C8A666963 @default.
- Q70558147 P2860 Q70558147-2A16A826-1BEB-4F84-97E7-AE44587BD55B @default.
- Q70558147 P2860 Q70558147-2D3E1202-F518-4452-83BD-0AA5BA7EE8D5 @default.
- Q70558147 P2860 Q70558147-3D0EBCA7-D7CA-4DBD-98A4-A9F53C767840 @default.
- Q70558147 P2860 Q70558147-4A3A0C5B-EEB1-4BB9-A521-EABA73758291 @default.
- Q70558147 P2860 Q70558147-4CA9B13C-04AF-4941-BD5D-0CB5212F57A7 @default.
- Q70558147 P2860 Q70558147-583B3600-494B-4202-9840-597B76CB28D7 @default.
- Q70558147 P2860 Q70558147-58614951-20A3-4412-AA5E-3408C6D77030 @default.
- Q70558147 P2860 Q70558147-6CA190B9-F35F-44C8-803D-A81CEA22BBDC @default.
- Q70558147 P2860 Q70558147-6D94DEB8-EEF2-4EEC-8A6A-6DCF0C29B20C @default.
- Q70558147 P2860 Q70558147-71D1D8A4-5923-4E3E-AF70-8F0F970709DB @default.
- Q70558147 P2860 Q70558147-73540AD8-5A61-409F-99EF-BC73F030BB5B @default.
- Q70558147 P2860 Q70558147-752C20C3-9D26-48BF-9803-CEB169B794B8 @default.
- Q70558147 P2860 Q70558147-7AC07BCA-0C58-4EE5-AAA6-6103B2F7E70F @default.
- Q70558147 P2860 Q70558147-8271F4AE-67FE-4E79-95DB-E4FB9E0D6F06 @default.
- Q70558147 P2860 Q70558147-8EBE22D7-4CBB-4DDF-BE0B-08EE258354B7 @default.
- Q70558147 P2860 Q70558147-8FB51FE6-AD4B-4884-BC65-87948635CF79 @default.
- Q70558147 P2860 Q70558147-9760158B-5A6E-42E2-B3F4-2EBC55B37F7C @default.
- Q70558147 P2860 Q70558147-B12B6614-8CAF-468C-B1A9-B5CEF5F58C34 @default.
- Q70558147 P2860 Q70558147-BA552405-103E-4A81-9DD0-23D5045D3170 @default.
- Q70558147 P2860 Q70558147-BD1894BB-9B4A-4D85-9DDD-BC2F4CBBEFA1 @default.
- Q70558147 P2860 Q70558147-BFE0D1CF-BB49-4F0C-8D82-B808D2883D75 @default.
- Q70558147 P2860 Q70558147-C92ABAA4-8382-48A9-82E2-624840A61B9A @default.
- Q70558147 P2860 Q70558147-D29D831F-AFE2-4DD7-B59A-29AB1D1557E5 @default.
- Q70558147 P2860 Q70558147-D4590BA7-29FA-4683-8CF4-8BC59F5C3092 @default.
- Q70558147 P2860 Q70558147-D5D8AFF5-0627-4648-8E3E-46E9E80E59F1 @default.
- Q70558147 P2860 Q70558147-F076ACB1-ACC7-41EC-A928-17C607C0E4AF @default.
- Q70558147 P2860 Q70558147-FF4E828D-C812-44C8-8ADA-4EE07A4286E7 @default.
- Q70558147 P2888 Q70558147-ABC0968F-22BF-4A04-B74F-F3A823500A81 @default.
- Q70558147 P304 Q70558147-A187E542-46B9-4B48-9E58-B63D5F9270CB @default.
- Q70558147 P31 Q70558147-D57D35D2-0A6D-43A0-B135-2689E306D3D2 @default.
- Q70558147 P356 Q70558147-B4DA9093-B1B3-454E-B1B7-E7D81771BB5E @default.
- Q70558147 P433 Q70558147-38110000-324F-41F2-AC85-8B359EF32BEF @default.
- Q70558147 P478 Q70558147-B5570CCC-7B3C-47A1-AC77-7A4AEDF8517A @default.
- Q70558147 P577 Q70558147-A6790821-FC78-4985-991D-DC0F80F4DAAE @default.
- Q70558147 P698 Q70558147-820CF64F-F60D-4423-934B-E3338F610150 @default.
- Q70558147 P921 Q70558147-02F8EA91-1F90-4114-8BCF-DD52528ED89F @default.
- Q70558147 P921 Q70558147-E9F8FE68-A1D5-4619-A22C-2A00779EFDB8 @default.
- Q70558147 P356 BF00686148 @default.
- Q70558147 P698 8431969 @default.
- Q70558147 P1433 Q326137 @default.
- Q70558147 P1476 "Phase I study using desferrioxamine and iron sorbitol citrate in an attempt to modulate the iron status of tumor cells to enhance doxorubicin activity" @default.
- Q70558147 P2093 "A W Dekker" @default.
- Q70558147 P2093 "B S van Asbeck" @default.
- Q70558147 P2093 "E E Voest" @default.
- Q70558147 P2093 "F E Ros" @default.
- Q70558147 P2093 "J E Keunen" @default.
- Q70558147 P2093 "J J Marx" @default.
- Q70558147 P2093 "J P Neijt" @default.
- Q70558147 P2093 "J W Nortier" @default.
- Q70558147 P2860 Q28331893 @default.
- Q70558147 P2860 Q28359636 @default.
- Q70558147 P2860 Q29620070 @default.
- Q70558147 P2860 Q34326858 @default.
- Q70558147 P2860 Q34486088 @default.
- Q70558147 P2860 Q35158610 @default.
- Q70558147 P2860 Q37875066 @default.
- Q70558147 P2860 Q37922384 @default.
- Q70558147 P2860 Q41701932 @default.
- Q70558147 P2860 Q41905204 @default.
- Q70558147 P2860 Q41907864 @default.
- Q70558147 P2860 Q42199254 @default.
- Q70558147 P2860 Q42209452 @default.
- Q70558147 P2860 Q42216348 @default.
- Q70558147 P2860 Q42216733 @default.
- Q70558147 P2860 Q42241925 @default.
- Q70558147 P2860 Q42256501 @default.